THE BROAD VIEW
·
SUBSCRIBERS
Bolder biotech investments, not less, is key to better health outcomes for all
The goal is expanding access to drugs and the types of patients that can benefit from treatments.
Published Sat, Dec 14, 2024 · 05:00 AM
HEALTHCARE costs are rising globally. This is driven by ageing populations, lifestyle demographic shifts, newer treatments being offered, and a skilled manpower shortage.
Since the Covid-19 pandemic, inflationary pressures have been experienced across the healthcare industry. The WTW Global Medical Trends Survey projects more than 10 per cent increase in medical costs in 2025.
Yet, evidence of an association between healthcare costs and quality outcomes is inconsistent.
Share with us your feedback on BT's products and services
